MIRUM PHARMACEUTICALS INC
MIRM · NASDAQ
Updated at 2026-10-15 08:18:06
- Today's High
- $81.90
- Today’s Low
- $78.35
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $78.41
- Previous Close
- $79.96
- Volume
- 975.11K
- Market Cap
- $5.19B
- P/E Ratio
- --
- EPS
- $-14.54
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 989 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA, UNITED STATES, 94404
- Country
- US
- Listing Date
- 2019-07-18
- Fiscal Year End
- December
- Shares Outstanding
- 60.98M
- CIK
- 0001759425
- Website
- mirumpharma.com
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.
Financial Metrics
Revenue
2026-06-30
$176.24M
2026-03-31
$159.88M
2025-12-31
$148.93M
2025-09-30
$133.01M
Operating Expenses
2026-06-30
$188.43M
2026-03-31
$194.24M
2025-12-31
$125.23M
2025-09-30
$104.87M
Net Income
2026-06-30
-$67.22M
2026-03-31
-$790.15M
2025-12-31
-$5.73M
2025-09-30
$2.9M
Net Profit Margin
2026-06-30
-38.14%
2026-03-31
-494.21%
2025-12-31
-3.84%
2025-09-30
2.18%
Earnings Per Share
2026-06-30
$-0.80
2026-03-31
$-1.08
2025-12-31
$-0.12
2025-09-30
$0.05
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$11.36M
2026-03-31
-$779.19M
2025-12-31
$4.7M
2025-09-30
$9.06M
Effective Tax Rate
2026-06-30
-2.57%
2026-03-31
-0.06%
2025-12-31
-15.45%
2025-09-30
-9.91%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $176.24M | $159.88M | $148.93M | $133.01M |
| Operating Expenses | $188.43M | $194.24M | $125.23M | $104.87M |
| Net Income | -$67.22M | -$790.15M | -$5.73M | $2.9M |
| Net Profit Margin | -38.14% | -494.21% | -3.84% | 2.18% |
| Earnings Per Share | $-0.80 | $-1.08 | $-0.12 | $0.05 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$11.36M | -$779.19M | $4.7M | $9.06M |
| Effective Tax Rate | -2.57% | -0.06% | -15.45% | -9.91% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.